LEXSTON LIFE SCIENCES CORP. APPOINTS CFO, MAKES CHANGES TO THE AUDIT COMMITTEE
Vancouver, British Columbia, March 25, 2022. Lexston Life Sciences Corp. (CSE: LEXT) (the “Company” or “Lexston”) announces the resignation of Dimitrios Mitrakos as the Chief Financial Officer and Corporate Secretary of the Company and the appointment of Company’s director Jatinder Jesse Manhas as the Chief Financial Officer and Corporate Secretary of the Company.
The Company also announces the appointment of director Graeme Staley to the audit committee of the Company. The audit committee of the Company now consists of directors Jagdip Singh Bal, Harinder Bains and Graeme Staley.
The Company thanks Mr. Mitrakos for his service as the Chief Financial Officer and Corporate Secretary.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Chief Executive Oﬃcer
Telephone: (604) 928-8913
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
929 Mainland Street Vancouver, BC V6B 1S3
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, or achievements of LEXT to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.